A Study of the Effect and Safety of HS-10390 in the Treatment of Participants With Chronic Kidney Disease

by | Apr 28, 2026 | Clinical Trials | 0 comments

​ Conditions: Chronic Kidney Disease

Interventions: Drug: HS-10390; Drug: HS-10390; Drug: HS-10390; Drug: Irbesartan

Sponsors: Jiangsu Hansoh Pharmaceutical Co., Ltd.

Not yet recruiting Conditions: Chronic Kidney Disease
Interventions: Drug: HS-10390; Drug: HS-10390; Drug: HS-10390; Drug: Irbesartan
Sponsors: Jiangsu Hansoh Pharmaceutical Co., Ltd.
Not yet recruiting 

Submit a Comment

Your email address will not be published. Required fields are marked *